The future of cardiac xenotransplantation
- PMID: 35264775
- PMCID: PMC10143783
- DOI: 10.1038/s41569-022-00684-y
The future of cardiac xenotransplantation
Abstract
Reflecting on the first genetically engineered pig-to-human heart transplantation in this Clinical Outlook article, we discuss the likely future of cardiac xenotransplantation. Initial clinical trials are expected to explore compassionate use as destination therapy in carefully selected adult patients and as a bridge to heart allotransplantation in infant patients with complex congenital heart disease.
Conflict of interest statement
D.K.C.C. is a consultant for eGenesis, but the opinions expressed in this article are his own and do not necessarily reflect those of the company. D.K.C.C. and R.N.P.III have received research materials and/or funding from eGenesis and Revivicor.
Figures

References
-
- Langin M et al. Consistent success in life-supporting porcine cardiac xenotransplantation. Nature 564, 430–433 (2018). - PubMed
-
- Buhlei L et al. High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response. Transplantation 69, 2296–2304 (2000). - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources